A Signal Processing Approach to Pharmacokinetic Data Analysis.


Journal

Pharmaceutical research
ISSN: 1573-904X
Titre abrégé: Pharm Res
Pays: United States
ID NLM: 8406521

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 25 07 2020
accepted: 04 11 2020
pubmed: 23 3 2021
medline: 9 11 2021
entrez: 22 3 2021
Statut: ppublish

Résumé

The connection between pharmacokinetic models and system theory has been established for a long time. In this approach, the drug concentration is seen as the output of a system whose input is the drug administered at different times. In this article we further explore this connection. We show that system theory can be used to easily accommodate any therapeutic regime, no matter its complexity, allowing the identification of the pharmacokinetic parameters by means of a non-linear regression analysis. We illustrate how to exploit the properties of linear systems to identify non-linearities in the pharmacokinetic data. We also explore the use of bootstrapping as a way to compare populations of pharmacokinetic parameters and how to handle the common situation of using multiple hypothesis tests as a way to distinguish two different populations. Finally, we demonstrate how the bootstrap values can be used to estimate the distribution of derived parameters, as can be the allometric scale factors.

Identifiants

pubmed: 33751326
doi: 10.1007/s11095-021-03000-4
pii: 10.1007/s11095-021-03000-4
doi:

Substances chimiques

Benzamides 0
Propanolamines 0
iosmin QPG0485VLS

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

625-635

Références

Bertrand J, Mentré F. Mathematical expressions of the pharmacokinetic and pharmacodynamic models implemented in the Monolix software. Tech Rep, INSERM U738, Paris Diderot University, 2008.
Cutler DJ. Linear systems analysis in pharmacokinetics. J Pharmacokinetics, Biopharmaceut. 1978;6:265–82.
doi: 10.1007/BF01312266
Pedersen PV. Model-independent method of analyzing input in linear pharmacokinetic systems having polyexponential impulse response i: theoretical analysis. J Pharm Sci. 1980;69:298–305.
doi: 10.1002/jps.2600690314
Pohjanpalo H. System identifiability based on the power series expansion of the solution. Math Biosci. 1978;41:21–33.
doi: 10.1016/0025-5564(78)90063-9
Weiss M, Föerster W. Pharmacokinetic model based on circulatory transport. Eur J Clin Pharmacol. 1979;16:287–93.
doi: 10.1007/BF00608408
Schwilden H. A general method for calculating the dosage scheme in linear pharmacokinetics. Eur J Clin Pharmacol. 1981;20(5):379–86.
doi: 10.1007/BF00615409
Sorzano COS, Pérez-De-La-Cruz Moreno MA, Burguet-Castell J, Montejo C, Aguilar Ros A. Cost-constrained optimal sampling for system identification in pharmacokinetics applications with population priors and nuisance parameters. J Pharm Sci. 2015;104(6):2103–9.
doi: 10.1002/jps.24417
Sorzano C.O.S. A signal processing approach to pharmacokinetics, pharmacodynamics and biopharmaceutics data analysis, Ph.D. thesis, Univ. San Pablo CEU, 2015.
Bakar SK, Niazi S. Simple reliable method for chronic cannulation of the jugular vein for pharmacokinetic studies. J Pharm Sci. 1983;72:1027–9.
doi: 10.1002/jps.2600720915
Gabrielsson J, Weiner D. Pharmacokinetic and pharmacodynamics data analysis: concepts and applications. 4
Committee for Medicinal Products for Human Use (CHMP). Guideline on bioanalytical method validation, European Medicines Agency, 2011.
Sheskin DJ. Handbook of parametric and nonparametric statistical procedures, Chapman & Hall/CRC, 2004.
Mathews P. Sample size calculations, Mathews Malnar and Bailey, Inc. 2010.
Wakefield J, Aarons L, Racine-Poon A. The Bayesian approach to population pharmacokinetic/pharmacodynamic modeling. Case studies in Bayesian Statistics, pp205–265, 1999.
Matis JH. An introduction to stochastic compartmental models in pharmacokinetics. Pharmacokinetics. NATO ASI Series. 1988;145:113–28.

Auteurs

C O S Sorzano (COS)

National Center of Biotechnology, CSIC, Madrid, Spain. coss@cnb.csic.es.
University CEU San Pablo, Madrid, Spain. coss@cnb.csic.es.

M A Pérez-de-la-Cruz Moreno (MAP)

Actual: Chemo Group, Madrid, Spain.

F R Martín (FR)

University CEU San Pablo, Madrid, Spain.

C Montejo (C)

University CEU San Pablo, Madrid, Spain.

A Aguilar-Ros (A)

University CEU San Pablo, Madrid, Spain.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH